European Commission secures EU access to Remdesivir for treatment of COVID-19

European Commission Press release Brussels, 29 Jul 2020 Yesterday, the European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir.